These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15542539)

  • 21. Pharmacokinetics and pharmacodynamics of rocuronium bromide in adult patients.
    Alvarez-Gomez JA; Estelles ME; Fabregat J; Perez F; Brugger AJ
    Eur J Anaesthesiol Suppl; 1994; 9():53-6. PubMed ID: 7925209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study.
    Staals LM; Snoeck MM; Driessen JJ; van Hamersvelt HW; Flockton EA; van den Heuvel MW; Hunter JM
    Br J Anaesth; 2010 Jan; 104(1):31-9. PubMed ID: 20007792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers.
    Cammu G; De Kam PJ; Demeyer I; Decoopman M; Peeters PA; Smeets JM; Foubert L
    Br J Anaesth; 2008 Mar; 100(3):373-9. PubMed ID: 18238834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic/pharmacodynamic modeling of rocuronium in myasthenic patients is improved by taking into account the number of unbound acetylcholine receptors.
    De Haes A; Proost JH; Kuks JB; van den Tol DC; Wierda JM
    Anesth Analg; 2002 Sep; 95(3):588-96, table of contents. PubMed ID: 12198043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study.
    Cammu G; de Kam PJ; De Graeve K; van den Heuvel M; Suy K; Morias K; Foubert L; Grobara P; Peeters P
    Br J Anaesth; 2010 Oct; 105(4):487-92. PubMed ID: 20630888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of acute normovolaemic haemodilution on the dose-response relationship, time-course of action and pharmacokinetics of rocuronium bromide.
    Dahaba AA; Perelman SI; Moskowitz DM; Bennett HL; Shander A; Oettl K; Reibnegger G; Metzler H
    Br J Anaesth; 2006 Oct; 97(4):482-8. PubMed ID: 16873389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of rocuronium during the three stages of liver transplantation.
    Fisher DM; Ramsay MA; Hein HA; Marcel RJ; Sharma M; Ramsay KJ; Miller RD
    Anesthesiology; 1997 Jun; 86(6):1306-16. PubMed ID: 9197300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of rocuronium in children aged 4-11 years.
    Vuksanaj D; Fisher DM
    Anesthesiology; 1995 May; 82(5):1104-10. PubMed ID: 7741284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacodynamics and pharmacokinetics of rocuronium following continuous infusion in patients during intravenous anaesthesia.
    Sparr HJ; Khuenl-Brady KS; Eriksson LI
    Eur J Anaesthesiol Suppl; 1994; 9():63-5. PubMed ID: 7925211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of rocuronium bromide in obese female patients.
    Pühringer FK; Keller C; Kleinsasser A; Giesinger S; Benzer A
    Eur J Anaesthesiol; 1999 Aug; 16(8):507-10. PubMed ID: 10500937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary, biliary and faecal excretion of rocuronium in humans.
    Proost JH; Eriksson LI; Mirakhur RK; Roest G; Wierda JM
    Br J Anaesth; 2000 Nov; 85(5):717-23. PubMed ID: 11094587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time course of action of sugammadex (Org 25969) on rocuronium-induced block in the Rhesus monkey, using a simple model of equilibration of complex formation.
    de Boer HD; van Egmond J; van de Pol F; Bom A; Driessen JJ; Booij LH
    Br J Anaesth; 2006 Nov; 97(5):681-6. PubMed ID: 17018564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioavailability of intramuscular rocuronium in infants and children.
    Reynolds LM; Lau M; Brown R; Luks A; Sharma M; Fisher DM
    Anesthesiology; 1997 Nov; 87(5):1096-105. PubMed ID: 9366462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Target controlled infusion of rocuronium: analysis of effect data to select a pharmacokinetic model.
    Vermeyen KM; Hoffmann VL; Saldien V
    Br J Anaesth; 2003 Feb; 90(2):183-8. PubMed ID: 12538375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-response relationship of rocuronium bromide during intravenous anaesthesia.
    Mellinghoff H; Diefenbach C; Bischoff A; Grond S; Buzello W
    Eur J Anaesthesiol Suppl; 1994; 9():20-4. PubMed ID: 7925204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of rocuronium bromide in patients with and without renal failure.
    Cooper RA; Mirakhur RK; Wierda JM; Maddineni VR
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():43-4. PubMed ID: 8557005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulatory model of vascular and interstitial distribution kinetics of rocuronium: a population analysis in patients.
    Weiss M; Reekers M; Vuyk J; Boer F
    J Pharmacokinet Pharmacodyn; 2011 Apr; 38(2):165-78. PubMed ID: 21125318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of the aminosteroidal non-depolarizing neuromuscular blocking agents rocuronium and vecuronium in plasma with liquid chromatography-tandem mass spectroscopy.
    Gutteck-Amsler U; Rentsch KM
    Clin Chem; 2000 Sep; 46(9):1413-4. PubMed ID: 10973876
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemical encapsulation of rocuronium by synthetic cyclodextrin derivatives: reversal of neuromuscular block in anaesthetized Rhesus monkeys.
    de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
    Br J Anaesth; 2006 Feb; 96(2):201-6. PubMed ID: 16377646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl.
    Wierda JM; Kleef UW; Lambalk LM; Kloppenburg WD; Agoston S
    Can J Anaesth; 1991 May; 38(4 Pt 1):430-5. PubMed ID: 1829656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.